An in silico and in vitro human neuronal network model reveals cellular mechanisms beyond NaV1.1 underlying Dravet syndrome

Stem Cell Reports. 2023 Aug 8;18(8):1686-1700. doi: 10.1016/j.stemcr.2023.06.003. Epub 2023 Jul 6.

Abstract

Human induced pluripotent stem cell (hiPSC)-derived neuronal networks on multi-electrode arrays (MEAs) provide a unique phenotyping tool to study neurological disorders. However, it is difficult to infer cellular mechanisms underlying these phenotypes. Computational modeling can utilize the rich dataset generated by MEAs, and advance understanding of disease mechanisms. However, existing models lack biophysical detail, or validation and calibration to relevant experimental data. We developed a biophysical in silico model that accurately simulates healthy neuronal networks on MEAs. To demonstrate the potential of our model, we studied neuronal networks derived from a Dravet syndrome (DS) patient with a missense mutation in SCN1A, encoding sodium channel NaV1.1. Our in silico model revealed that sodium channel dysfunctions were insufficient to replicate the in vitro DS phenotype, and predicted decreased slow afterhyperpolarization and synaptic strengths. We verified these changes in DS patient-derived neurons, demonstrating the utility of our in silico model to predict disease mechanisms.

Keywords: Dravet Syndrome; SCN1A; computational model; disease modeling; humen induced pluripotent stem cells; iPSC; multi-electrode arrays; neuronal network activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Epilepsies, Myoclonic* / genetics
  • Humans
  • Induced Pluripotent Stem Cells*
  • Mutation
  • Mutation, Missense
  • NAV1.1 Voltage-Gated Sodium Channel / genetics
  • Neurons / physiology

Substances

  • NAV1.1 Voltage-Gated Sodium Channel